ELectronic Alerts Intiative Association (ELAIA)

Overview

With the proliferation of the electronic health record, automated "alerts" have proliferated.  Alerts can remind providers about drug-drug interactions, necessary screening tests, or even notify them of possible diagnoses.  Despite their ubiquity, the efficacy of alerts has rarely been measured in a systematic fashion.  If alerting is not assessed appropriately, potentially ineffective alerts will proliferate, which can cause fatigue, whereby providers begin to ignore alerts that may be important.


The ELAIA projects seek to evaluate the efficacy of electronic alerts for Acute Kidney Injury by using randomized trial designs.  Trials will examine the efficacy of AKI alerts by various mechanisms, the efficacy of AKI alerts in the setting of key kidney-toxic drugs, and the ability to target alerts using uplift modeling.

Bio Profile

Francis Perry Wilson, MD, MS

Principal Investigator

Assistant Professor of Medicine (Nephrology)

View Full Profile

Bio Profile

Chirag R Parikh, MD, PhD, FACP

Professor of Medicine (Nephrology)

Director, Program of Applied Translational Research

View Full Profile

Bio Profile

Haiqun Lin, MD, PhD

Associate Professor of Biostatistics

View Full Profile

Aditya Biswas

Postgraduate Associate, Yale University

Harold Feldman, MD, MSCE

George S. Pepper Professor of Public Health and Preventative Medicine, Yale University

Amit Garg, MD, PhD

Professor of Medicine (Nephrology), Western University, London, Ontario, Canada

Stephen Latham, JD, PhD

Director, Interdisciplinary Center for Bioethics, Yale University

Paul M. Palevsky, MD

Professor of Medicine, Renal-Electrolyte Division, University of Pittsburgh


ELAIA Publications

Contact Information

For more information, or if you are interested in collaborating on this study, please contact F. Perry Wilson

Project Funding

Funding for this project comes, in part, from the following grant:

K23 DK097201 

"Mediators & Prognostic Value of Muscle Mass & Function in Chronic Kidney Disease" 


Twitter Feed

@methodsmanmd